These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7301316)

  • 21. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
    Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
    Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous vitreous hemorrhage: etiology and management.
    Winslow RL; Taylor BC
    South Med J; 1980 Nov; 73(11):1450-2. PubMed ID: 7444506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vitrectomy via pars plana. A histological study and an analysis of clinical results (author's transl)].
    Gnad HD
    Wien Klin Wochenschr Suppl; 1980; 108():1-22. PubMed ID: 6769257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of complex retinal detachments by vitrectomy and fluid/silicone exchange.
    Lean JS; Leaver PK; Cooling RJ; McLeod D
    Trans Ophthalmol Soc U K (1962); 1982 Apr; 102 (Pt 1)():203-5. PubMed ID: 6963058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy.
    Wilson-Holt N; Khaw P; Savage F; Grierson I
    Br J Ophthalmol; 1992 Mar; 76(3):159-62. PubMed ID: 1540560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary efficacy and safety of a silicone oil-filled foldable capsular vitreous body in the treatment of severe retinal detachment.
    Lin X; Wang Z; Jiang Z; Long C; Liu Y; Wang P; Jin C; Yi C; Gao Q
    Retina; 2012 Apr; 32(4):729-41. PubMed ID: 22105508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
    Chen W; Lu Q; Lu L; Guan H
    Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the efficacy and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment].
    Yan YN; Tian B; Liu Q; Wei WB
    Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):259-266. PubMed ID: 30982287
    [No Abstract]   [Full Text] [Related]  

  • 31. Prophylactic vitrectomy in proliferative diabetic retinopathy.
    Blankenship GW; Machemer R
    Mod Probl Ophthalmol; 1977; 18():236-41. PubMed ID: 876057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vitreous surgery for intraocular proliferative disorders].
    Tano Y
    Nippon Ganka Gakkai Zasshi; 1991 May; 95(5):405-20. PubMed ID: 1872211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
    Deng J; Wu DZ; Gao R
    Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early vitrectomy in proliferative diabetic retinopathy.
    Shea M
    Arch Ophthalmol; 1983 Aug; 101(8):1204-5. PubMed ID: 6882246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual outcome in moderate and severe proliferative diabetic retinopathy.
    Spencer R; McMeel JW; Franks EP
    Arch Ophthalmol; 1981 Sep; 99(9):1551-4. PubMed ID: 6169328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
    Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
    Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of retinopathy of incontinentia pigmenti by anti-vascular endothelial growth factor].
    Wang X; Liang JH
    Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):294-301. PubMed ID: 30982292
    [No Abstract]   [Full Text] [Related]  

  • 38. Silicone oil for retinal detachment with advanced proliferative vitreoretinopathy following failed vitrectomy for proliferative diabetic retinopathy.
    Rinkoff JS; de Juan E; McCuen BW
    Am J Ophthalmol; 1986 Feb; 101(2):181-6. PubMed ID: 3946533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retinal detachment recurrences. 2. Mechanisms and treatment (author's transl)].
    Girard P; Rouillac A; Bokobza Y; Kohen D; Forest A
    J Fr Ophtalmol; 1982; 5(2):103-7. PubMed ID: 7200499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical mediators of intraocular neovascularization.
    Glaser BM; D'Amore PA; Lutty GA; Fenselau AH; Michels RG; Patz A
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):369-73. PubMed ID: 6171070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.